The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early outcomes of the PLATO ACT5 randomised trial: Personalizing anal cancer radiotherapy dose.
 
Maria Hawkins
No Relationships to Disclose
 
Alexandra Gilbert
Research Funding - Adlai Nortye (Inst)
 
Richard Adams
Honoraria - Amgen; AstraZeneca; Bayer; SERVIER; Takeda; Teysuno
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Seagen; SERVIER
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; SERVIER
 
Lindy Berkman
No Relationships to Disclose
 
Joanne Copeland
No Relationships to Disclose
 
Duncan Gilbert
No Relationships to Disclose
 
Mark Harrison
No Relationships to Disclose
 
Robert Glynne-Jones
Consulting or Advisory Role - Amgen; Incyte
Speakers' Bureau - SERVIER
 
Vicky Goh
Speakers' Bureau - Bayer Schering Pharma; Siemens Healthineers
Research Funding - Siemens Healthineers
Travel, Accommodations, Expenses - Siemens Healthineers
 
Chloe Gaul
No Relationships to Disclose
 
Andrew Renehan
No Relationships to Disclose
 
Rebecca Muirhead
No Relationships to Disclose
 
Matthew Norris
No Relationships to Disclose
 
Sheela Rao
Honoraria - Bayer; GlaxoSmithKline; Incyte; Merck Serono; Servier (I)
Consulting or Advisory Role - AstraZeneca; Bayer; Incyte; Nordic Bioscience
Speakers' Bureau - Incyte; Merck Serono; SERVIER; Takeda
Travel, Accommodations, Expenses - MSD Oncology; SERVIER; Takeda Science Foundation
 
Susan Richman
Patents, Royalties, Other Intellectual Property - IHC Patent pending. Filed by Roche, in collaboration with the University of Leeds. Technology Title: Scoring algorithm using EREG and AREG for prediction of response to EGFR directed therapies US Patent Filing: US 62/706,988
 
Sharon Ruddock
No Relationships to Disclose
 
Joanne Webster
No Relationships to Disclose
 
Sarah Brown
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst)
 
David Sebag-Montefiore
No Relationships to Disclose